Tech Company Inital Public Offerings
Eliem Therapeutics IPO
Eliem Therapeutics, based in Redmond, debuted as a public company on 8/10/2021.
Transaction Overview
Company Name
Announced On
8/10/2021
Transaction Type
IPO
Amount
$56,250,000
Proceeds Purpose
Use of proceeds for the Eliem Therapeutics IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
23515 NE Novelty Hill Rd. B221 #125
Redmond, WA 98053
USA
Redmond, WA 98053
USA
Phone
Undisclosed
Website
Email Address
Overview
At its core, Eliem is motivated by the promise of helping people live happier, more fulfilling lives. The Eliem team channels its experience, energy and passion for improving patients' quality of life by developing life-changing novel therapies for neuronal excitability disorders based on clinically validated mechanisms of action.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Azelby
Chief Medical Officer
Amy Chappell
Chief Operating Officer
Erin Lavelle
VP - Bus. Development
Jo Palmer-Phillips
VP - General Counsel
James Bucher
VP - R & D
Valerie Morisset
Browse more venture capital transactions:
Prev: 8/9/2021: CoinDCX venture capital transaction
Next: 8/10/2021: Verifiable venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs